Previous 10 | Next 10 |
The coronavirus outbreak and the effects of COVID-19 have gone deeper and wider than most people would have expected. That applies just as much to markets as anywhere. Whether it's a tech sector that is supporting our new work from home or re-rating as expensive EV/Sales multiples make less se...
As the health crisis spirals into a financial one, the liquidation and panic selling have indiscriminately hit sectors across the board. The biotechs were no exception, with the S&P Biotech ETF ( XBI ) plummeting -20% on the year in tandem with the S&P 500 (SPY). Source: WingCapital...
That which is common to the greatest number has the least care bestowed upon it, everybody is more inclined to neglect the duty which he expects another to fulfill.” - Aristotle, Politics Markets stabilized somewhat last week after a month of Wuhan coronavirus or Covid-19-trigge...
We're living out the memorable opening line of Charles Dickens' classic novel A Tale of Two Cities . It really is both the best of times and the worst of times. Identifying what makes this the worst of times is easy. The coronavirus pandemic has arguably caused the greatest disruption to every...
I am constantly looking to provide valuable information to my readers on how to outperform the market while taking few risks. A very strong strategy to outperform the market is following insider purchases, as literature has proven that this strategy could beat the market by as much as 24.20% p...
There are a lot of stocks that are much cheap er than they've been in a while. That doesn't necessarily make them cheap, though. Think about it this way: Someone could cut the price of a pet rock from $10,000 to $5,000, but it still wouldn't be a bargain. However, there are some stocks t...
Whether you're a novice investor who's just getting your feet wet or you've seen your fair share of bear markets, you've witnessed history over the past five weeks. In a span of 23 sessions since the S&P 500 hit its all-time closing high, the benchmark index has logged 10 of its 13 largest...
Goldman's David Kostin screened S&P 500 stocks looking for "Benjamin Graham-inspired safety stocks" that he says based on size, liquidity, balance sheet strength, and valuation, offer a margin of safety. More news on: Intel Corporation, Alexion Pharmaceuticals, Inc., Align Technology, ...
We are truly witnessing some unprecedented events unfold before our eyes. In about a month, coronavirus disease 2019 (COVID-19) went from being a sparse illness in the U.S. that was primarily ravaging parts of China to a global pandemic. As of Monday, March 16, more than 181,500 cases of COVID-...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
News, Short Squeeze, Breakout and More Instantly...
Alexion Pharmaceuticals Inc. Company Name:
ALXN Stock Symbol:
NASDAQ Market:
Alexion Pharmaceuticals Inc. Website:
AstraZeneca (NASDAQ: AZN) hopes to soon close its planned acquisition of Alexion Pharmaceuticals (NASDAQ: ALXN) . The only hurdle left to jump is obtaining approval from United Kingdom regulators. In this Motley Fool Live video recorded on July 7 , Motley Fool contri...
This week, pharma and biotech giant AstraZeneca (NASDAQ: AZN) cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ: ALXN) when it announced that the deal had received clearance from the United Kingdom's Compet...